4
Changes in Ownership
Cytek Biosciences, Inc. Filed Acc 0001209191-22-062882
Chief Financial Officer sold 3,500 shares at $9.77 ($34,195)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Jeanmonod Patrik Chief Financial Officer | 2022-12-27 | Sale | −3,500 | $9.77 | $34,195 | 79,632 | D |
| Open-market sales · 3,500 sh · avg $9.77 · $34,195 | |||||||
Loading xslF345X03/doc4.xml…